← Leaderboards
Christian Jobin
University Of Florida
$16,517,406
Attributed
$23,863,479
Total exposure
16
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,863,479 · 16
By mechanism
R01$20,964,947 · 8
R21$2,331,834 · 6
R56$331,090 · 1
P30$235,608 · 1
Top collaborators
- Seth B. Herzon8 shared
- Steven D Bruner5 shared
- Jason Michael Crawford5 shared
- Jean-Pierre J Issa5 shared
- Shengmin Sang5 shared
- Daniel W Rosenberg3 shared
- Lynn El Haddad2 shared
- Raad Gharaibeh2 shared
Most similar at University Of Florida
Same institution · by research overlap
- Jose A Lemos$13,216,214
- Alexandra Peterson$87,604
Others in their field
Top investigators on “Bacteria”
- James E. Gern · University Of Wisconsin-Madison$138,333,846
- Ian A Wilson · Scripps Research Institute, The$90,122,969
- Vance G Fowler · Duke University$85,101,521
- Henry F Chambers · Duke University$84,838,080
- Timothy Henkel · Venatorx Pharmaceuticals, Inc.$48,397,895
- David Alland · Rutgers Biomedical And Health Sciences$47,292,355
Research focus
BacteriaMediatingInflammationColorectal CancerMalignant NeoplasmsPreventTumorIntestinesEscherichia ColiComplexMicrobialInflammatory Bowel DiseasesImmune ResponseColitisProductionResponseCarcinogenesisGnotobioticPathway InteractionsGenesMicrobiomeMicrobiotaBaseSignal Transduction
Grant awards (67)
Structural and functional studies of colibactin$660,696
R01 · FY2025 · CA
Microbiota, Metabolites, and Colon Neoplasia$575,313
R01 · FY2025 · CA
Role of bacterial-derived small molecules in immunotherapy$540,288
R01 · FY2025 · CA · contact PI
Interaction between dietary taurine and microbiota sulfur metabolism in the development of colorectal cancer$536,489
R01 · FY2025 · CA · contact PI
Cancer Therapeutics and Host Response Research Program$79,912
P30 · FY2025 · CA · contact PI
Structural and functional studies of colibactin$627,662
R01 · FY2024 · CA
Microbiota, Metabolites, and Colon Neoplasia$557,628
R01 · FY2024 · CA
Deciphering microbial contribution to androgen bioavailability in castration resistant prostate cancer patients$148,419
R21 · FY2024 · CA
Cancer Therapeutics and Host Response Research Program$77,848
P30 · FY2024 · CA · contact PI
Structural and functional studies of colibactin$677,571
R01 · FY2023 · CA
Microbiota, Metabolites, and Colon Neoplasia$631,851
R01 · FY2023 · CA
Role of Bacteria in Colitis-Associated Colon Cancer$429,377
R01 · FY2023 · DK · contact PI
Bacteriophage-mediated microbiota modification to prevent colorectal cancer development$209,604
R21 · FY2023 · CA
Deciphering microbial contribution to androgen bioavailability in castration resistant prostate cancer patients$207,931
R21 · FY2023 · CA
Microbiota-mediated enhancement of the anti-tumor effect of natural killer cells$174,670
R21 · FY2023 · CA
Cancer Therapeutics and Host Response Research Program$77,848
P30 · FY2023 · CA · contact PI
Chemical approaches toward the identification, functional analysis, and biosynthesis of small molecule cyclomodulins$573,414
R01 · FY2022 · CA
Role of the microbiota in DNA methylation and CRC development$570,926
R01 · FY2022 · CA
Role of Bacteria in Colitis-Associated Colon Cancer$429,377
R01 · FY2022 · DK · contact PI
Microbiota-mediated enhancement of the anti-tumor effect of natural killer cells$213,881
R21 · FY2022 · CA
Modulation of microbiome function by host-derived noncoding small RNA$188,420
R21 · FY2022 · AI · contact PI
Bacteriophage-mediated microbiota modification to prevent colorectal cancer development$178,234
R21 · FY2022 · CA
Chemical approaches toward the identification, functional analysis, and biosynthesis of small molecule cyclomodulins$585,115
R01 · FY2021 · CA
Role of the microbiota in DNA methylation and CRC development$564,123
R01 · FY2021 · CA
Modulation of microbiome function by host-derived noncoding small RNA$226,545
R21 · FY2021 · AI · contact PI
Role of the microbiota in DNA methylation and CRC development$600,157
R01 · FY2020 · CA
Chemical approaches toward the identification, functional analysis, and biosynthesis of small molecule cyclomodulins$585,115
R01 · FY2020 · CA
Role of Bacteria in Colitis-Associated Colon Cancer$429,377
R01 · FY2020 · DK · contact PI
Role of the microbiota in DNA methylation and CRC development$602,612
R01 · FY2019 · CA
Chemical approaches toward the identification, functional analysis, and biosynthesis of small molecule cyclomodulins$569,560
R01 · FY2019 · CA
Role of Bacteria in Colitis-Associated Colon Cancer$489,882
R01 · FY2019 · DK · contact PI
Impact of microbiota-mediated biotransformation of black tea polyphenols$411,381
R01 · FY2019 · AT · contact PI
Chemical approaches toward the identification, functional analysis, and biosynthesis of small molecule cyclomodulins$604,052
R01 · FY2018 · CA
Role of the microbiota in DNA methylation and CRC development$567,545
R01 · FY2018 · CA
Role of Bacteria in Colitis-Associated Colon Cancer$489,882
R01 · FY2018 · DK · contact PI
Impact of microbiota-mediated biotransformation of black tea polyphenols$412,828
R01 · FY2018 · AT · contact PI
Impact of microbiota-mediated biotransformation of black tea polyphenols$414,247
R01 · FY2017 · AT · contact PI
Mechanism by which H2S-producing bacteria influence development of colorectal cancer$195,924
R21 · FY2017 · CA · contact PI
Role of Bacteria in Colitis-Associated Colon Cancer$437,000
R01 · FY2016 · DK · contact PI
Impact of microbiota-mediated biotransformation of black tea polyphenols$415,510
R01 · FY2016 · AT · contact PI
Mechanism by which H2S-producing bacteria influence development of colorectal cancer$171,275
R21 · FY2016 · CA · contact PI
Impact of microbiota-mediated biotransformation of black tea polyphenols$478,509
R01 · FY2015 · AT · contact PI
Role of Bacteria in Colitis-Associated Colon Cancer$424,228
R01 · FY2015 · DK · contact PI
The role of klebsiella pneumonia-derived colibactin in colitis-associated colon cancer$12,773
R01 · FY2015 · DK · contact PI
Role of Bacteria in Colitis-Associated Colon Cancer$359,809
R01 · FY2014 · DK · contact PI
Regulation of immunosuppressive molecules in IBD$283,673
R01 · FY2014 · DK · contact PI
Regulation of immunosuppressive molecules in IBD$271,919
R01 · FY2013 · DK · contact PI
Role of Bacteria in Colitis-Associated Colon Cancer$251,198
R01 · FY2013 · DK · contact PI
Role of Bacteria in Colitis-Associated Colon Cancer$93,962
R01 · FY2013 · DK · contact PI
Role of Bacteria in Colitis-Associated Colon Cancer$367,921
R01 · FY2012 · DK · contact PI
Regulation of immunosuppressive molecules in IBD$246,214
R01 · FY2012 · DK · contact PI
Regulation of immunosuppressive molecules in IBD$279,890
R01 · FY2011 · DK · contact PI
Molecular Mechanisms of Campylobacter Jejuni-induced Pathogenesis$224,679
R21 · FY2011 · AI · contact PI
Regulation of immunosuppressive molecules in IBD$333,000
R01 · FY2010 · DK · contact PI
Role of Bacteria in Colitis-associated Colon Cancer$290,381
R01 · FY2010 · DK · contact PI
Molecular Mechanisms of Campylobacter Jejuni-induced Pathogenesis$192,252
R21 · FY2010 · AI · contact PI
Regulation of immunosuppresive molecules in IBD$331,090
R56 · FY2009 · DK · contact PI
Role of Bacteria in Colitis-associated Colon Cancer$293,314
R01 · FY2009 · DK · contact PI
Role of Bacteria in Colitis-associated Colon Cancer$293,314
R01 · FY2008 · DK · contact PI
Regulation of immunosuppressive molecules in IBD$88,131
R01 · FY2008 · DK · contact PI
Role of Bacteria in Colitis-associated Colon Cancer$299,300
R01 · FY2007 · DK · contact PI
Regulation of immunosuppressive molecules in IBD$207,739
R01 · FY2007 · DK · contact PI
Regulation of immunosuppressive molecules in IBD$213,944
R01 · FY2006 · DK · contact PI
Regulation of immunosuppressive molecules in IBD$219,092
R01 · FY2005 · DK
Regulation of immunosuppressive molecules in IBD$219,092
R01 · FY2004 · DK
Regulation of immunosuppressive molecules in IBD$247,835
R01 · FY2003 · DK
REGULATION OF IMMUNOSUPPRESSIVE MOLECULES IN IBD$200,731
R01 · FY2002 · DK